Actively Recruiting
Attention Training Technique in Treatment of Anxiety and Depression in Coronary Heart Disease Patients
Led by Vestre Viken Hospital Trust · Updated on 2024-05-16
64
Participants Needed
2
Research Sites
107 weeks
Total Duration
On this page
Sponsors
V
Vestre Viken Hospital Trust
Lead Sponsor
O
Oslo University Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
Anxiety and depression are associated with work disability, lower participation rate in cardiac rehabilitation and unfavourable life style changes following a coronary heart disease (CHD) event. The prevalence of clinically significant symptoms of depression and anxiety in CHD patients has been estimated to 30-50%. Furthermore, depression and anxiety are associated with a significant increased risk of subsequent major adverse cardiovascular events and mortality in CHD patients. Psychological interventions for anxiety and depression in CHD patients have demonstrated small and uncertain effects of symptoms, and no effect on cardiovascular outcomes. Therefore, testing the effectiveness of specific psychological interventions that may affect central mechanisms for cardiovascular outcomes, has been requested. The Attention training (ATT) Study is a randomized controlled trial comparing group-attention training to wait-list control in 64 patients who experience significant anxiety and depression after a CHD event. It will also be explored whether reduction in psychological symptoms is correlated with changes in biological markers with a potential link to cardiovascular outcomes.
CONDITIONS
Official Title
Attention Training Technique in Treatment of Anxiety and Depression in Coronary Heart Disease Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Established coronary heart disease as main somatic disease
- Score of 8 or higher on either Hospital Anxiety and Depression Scale anxiety or depression subscale
- Age between 18 and 65 years
- Ability to understand and speak Norwegian
- Willingness and ability to give informed consent
You will not qualify if you...
- Current or past neurological illness
- Traumatic brain injury
- Current alcohol or substance dependency disorders
- Psychotic disorders
- Bipolar disorders
- Developmental disorders
- Mental retardation
- Cognitive impairment preventing informed consent or participation
- Acute suicidality
- Life expectancy less than 12 months
- Concurrent psychological intervention for emotional distress
- Antidepressant or anxiolytic medication started within the previous 8 weeks
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Hospital of Vestfold
Tønsberg, Vestfold and Telemark County, Norway, 3103
Not Yet Recruiting
2
Vestre Viken Trust Drammen hospital
Drammen, Viken County, Norway, 3004
Actively Recruiting
Research Team
J
John Munkhaugen, MD,PhD
CONTACT
T
Toril Dammen, MD,PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here